Skip to content

Evaluation Of The GE Monitor Product Line

Evaluation Of The GE Monitor Product Line

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00730119
Enrollment
0
Registered
2008-08-08
Start date
2001-10-31
Completion date
2010-05-31
Last updated
2017-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECG, Non-invasive Blood Pressure, Respiration, SpO2, Temperature

Keywords

Non-invasive Blood Pressure (NIBP), GE Monitor, Temperature, SpO2, Respiration, ECG

Brief summary

This investigation is a multi-center study that will demonstrate that the GE Monitor meets equivalency and/or accuracy and/or performance criteria. This investigation will compare the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG.

Interventions

None listed

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Minutes to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Signed informed consent from subject and/or guardian * Ability to maintain proper placement of cuff and/or probe and/or sensor * Presence of atrial fibrillation or other irregular heart rhythm (when applicable) * Ability to single or dual monitor NIBP, ECG, and/or SpO2, whether or not already being monitored for any or all of these parameters (SuperSTAT development study only)

Exclusion criteria

* Any subject deemed too unstable, by clinician's discretion, or for another reason deemed unacceptable for study by the clinician * Known dysrhythmias (when applicable) * Known disease state or medical condition that A) compromises circulation to the extremity, B) compromises musculo-skeletal integrity, or C) otherwise contraindicates use of a NIBP cuff and/or SpO2 sensor on an extremity or ECG patches on skin * Vigorous exercise prior to participating in the study * Excessive movement or excitability causing false values or no determinations * Known allergy to latex when latex products will be in contact with subject * Subjects who have eaten, drank, smoked or chewed gum in the preceding half hour (temperature parameter only) * Nasal/septal defects, cold and/or allergies that would not allow the subject to breathe through their nose (temperature parameter only) * Subjects with whom flammable anesthetics will be used. * Adult/pediatric subjects,(greater than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 12, but no more than 25 blood pressures on each extremity * Pediatric/neonatal subjects,(less than 1 year of age) who, at the clinician's discretion, could not tolerate approximately 10, but no more than 12 blood pressures on each extremity * Presence of pacemaker which makes the atrial fibrillation rhythm indistinguishable * Subject's limb circumference is outside of the manufacturer's recommended cuff range * Subject has Korotkoff sounds that persist to nearly zero (when applicable)

Design outcomes

Primary

MeasureTime frame
This investigation will compare values from the test device(s) to itself, or one of the reference parameters, or a combination of parameters, including NIBP, temperature, SpO2, respirations, and ECG.unlimited

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026